These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37147690)

  • 21. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II Administration in Patients With COVID-19 Shock.
    Ofosu-Barko K; Liu Y; Alkhatib Tamimi F; Al Husami W; Ganatra S; Resnic F; Shah SP
    Crit Pathw Cardiol; 2021 Jun; 20(2):100-102. PubMed ID: 33031192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
    Knotzer H; Poidinger B; Kleinsasser A
    Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.
    Wieruszewski PM; Wittwer ED; Kashani KB; Brown DR; Butler SO; Clark AM; Cooper CJ; Davison DL; Gajic O; Gunnerson KJ; Tendler R; Mara KC; Barreto EF
    Chest; 2021 Feb; 159(2):596-605. PubMed ID: 32882250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologic Response to Angiotensin II Treatment for Coronavirus Disease 2019-Induced Vasodilatory Shock: A Retrospective Matched Cohort Study.
    Leisman DE; Mastroianni F; Fisler G; Shah S; Hasan Z; Narasimhan M; Taylor MD; Deutschman CS
    Crit Care Explor; 2020 Oct; 2(10):e0230. PubMed ID: 33063034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selepressin, a novel selective vasopressin V
    Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
    Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
    Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
    Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II in septic shock.
    Jadhav AP; Sadaka FG
    Am J Emerg Med; 2019 Jun; 37(6):1169-1174. PubMed ID: 30935784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esmolol to Treat the Hemodynamic Effects of Septic Shock: A Randomized Controlled Trial.
    Cocchi MN; Dargin J; Chase M; Patel PV; Grossestreuer A; Balaji L; Liu X; Moskowitz A; Berg K; Donnino MW
    Shock; 2022 Apr; 57(4):508-517. PubMed ID: 35066509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How Effective is Angiotensin II in Decreasing Mortality of Vasodilatory Shock? A Systematic Review.
    Semedi BP; Rehatta NM; Soetjipto S; Nugraha J; Mahyuddin MH; Arnindita JN; Wairooy NAP
    Open Access Emerg Med; 2023; 15():1-11. PubMed ID: 36636460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.
    Tumlin JA; Murugan R; Deane AM; Ostermann M; Busse LW; Ham KR; Kashani K; Szerlip HM; Prowle JR; Bihorac A; Finkel KW; Zarbock A; Forni LG; Lynch SJ; Jensen J; Kroll S; Chawla LS; Tidmarsh GF; Bellomo R;
    Crit Care Med; 2018 Jun; 46(6):949-957. PubMed ID: 29509568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasopressor Therapy in the Intensive Care Unit.
    Russell JA; Gordon AC; Williams MD; Boyd JH; Walley KR; Kissoon N
    Semin Respir Crit Care Med; 2021 Feb; 42(1):59-77. PubMed ID: 32820475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of temperature management at 33 °C versus normothermia on survival in patients with vasopressor support after out-of-hospital cardiac arrest: a post hoc analysis of the TTM-2 trial.
    Düring J; Annborn M; Cariou A; Chew MS; Dankiewicz J; Friberg H; Haenggi M; Haxhija Z; Jakobsen JC; Langeland H; Taccone FS; Thomas M; Ullén S; Wise MP; Nielsen N
    Crit Care; 2022 Jul; 26(1):231. PubMed ID: 35909163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of dexmedetomidine on vasopressor requirements in patients with septic shock: a subgroup analysis of the Sedation Practice in Intensive Care Evaluation [SPICE III] Trial.
    Cioccari L; Luethi N; Bailey M; Shehabi Y; Howe B; Messmer AS; Proimos HK; Peck L; Young H; Eastwood GM; Merz TM; Takala J; Jakob SM; Bellomo R;
    Crit Care; 2020 Jul; 24(1):441. PubMed ID: 32678054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A PILOT STUDY OF ANGIOTENSIN II AS PRIMARY VASOPRESSOR IN CRITICALLY ILL ADULTS WITH VASODILATORY HYPOTENSION: THE ARAMIS STUDY.
    See EJ; Clapham C; Liu J; Khasin M; Liskaser G; Chan JW; Serpa Neto A; Costa Pinto R; Bellomo R
    Shock; 2023 May; 59(5):691-696. PubMed ID: 36930693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of angiotensin II as vasopressor in vasodilatory shock.
    Lumlertgul N; Ostermann M
    Future Cardiol; 2020 Nov; 16(6):569-583. PubMed ID: 32462921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ANGIOTENSIN II IN THE TREATMENT OF DISTRIBUTIVE SHOCK: A SYSTEMATIC-REVIEW AND META-ANALYSIS.
    Xourgia E; Exadaktylos AK; Chalkias A; Ziaka M
    Shock; 2024 Aug; 62(2):155-164. PubMed ID: 38888542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incidence of cardiovascular instability in patients receiving various vasopressor strategies for peri-intubation hypotension.
    Schmitt CJ; Mattson AE; Brown CS; Mara KC; Cabrera D; Sandefur BJ; Wieruszewski ED
    Am J Emerg Med; 2023 Mar; 65():104-108. PubMed ID: 36603354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.